Obermatt

Olympus

TYO:7733 · JP3201200007
Health Care Equipment & SuppliesX-Large

360

61
EV / EBIT60
Price / Owner Earnings41
Owner Earnings Yield73
Dividend Yield55
Price/Sales49
EV / Gross Profit95
Price/Book66
Return on Capital65
Cash Return on Capital67
Return on Equity43
EBIT Margin43
Gross Profitability71
Cash Conversion31
Accruals29
Owner Earnings Margin47
Sales growth34
Profit Growth11
Long-Term EPS Growth4
Owner Earnings Growth19
Reinvestment57
Price momentum30
Debt load34
Refinancing44
Debt Payback58
Liquidity42
Analyst ratings23
Opinion Changes74
Price Target Upside22
Market mood75
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Olympus clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryJapan
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeTSE
Founded1919
Employees5,693
ISINJP3201200007
Last UpdateApr 2, 2026
Themes
UrologyPulmonologyGastroenterologyOncologySurgeryOrthopaedicsEar Nose & Throat (ENT)RespiratoryBiomedical EngineeringConsumer ElectronicsHardwareManufacturingSoftware

Description

Olympus Corporation manufactures and sells precision machineries and instruments. Business Segments The company operates through several reportable segments, each focusing on distinct product lines and market needs. The primary segments include: E…

Analysis

Bargain bin

Olympus Corporation is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is fair. The owner-earnings multiple stands at 21.2×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 7% a year, against analyst forecasts of -1%. The gap between price and consensus is worth watching: demanding expectations.

Growth is tepid; the safety picture is sturdy. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
25
2023202420252026

All-time high

55

Jan 2023

All-time low

4

Jan 2025

Average rank

27

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
49
41
40
38
Price/Earnings
38
59
70
40
Price/Book
66
24
27
19
Dividend Yield
55
36
29
27
Value (overall)
59
31
36
39

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Olympus with its peers
PolyNovo
ASX:PNV
33
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Hogy Medical
TYO:3593
37
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Ansell
ASX:ANN
80
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Mani
TYO:7730
77
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Fisher & Paykel Healthcare
NZC:FPH
79
CountryNew Zealand
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Yokogawa Electric
TYO:6841
90
CountryJapan
IndustryElectronic Equipment, Instruments & Components
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →